BioInvent International AB (publ) (STO:BINV)
22.30
+0.35 (1.59%)
May 4, 2026, 5:29 PM CET
BioInvent International AB Employees
BioInvent International AB had 124 employees as of September 30, 2025. The number of employees increased by 9 or 7.83% compared to the same quarter last year.
Employees
124
Change
9
Growth
7.83%
Revenue / Employee
2.00M SEK
Profits / Employee
-3.08M SEK
Market Cap
1.47B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 124 | 9 | 7.83% |
| Jun 30, 2025 | 122 | 10 | 8.93% |
| Mar 31, 2025 | 118 | 9 | 8.26% |
| Dec 31, 2024 | 114 | 3 | 2.70% |
| Sep 30, 2024 | 115 | 7 | 6.48% |
| Jun 30, 2024 | 112 | 9 | 8.74% |
| Mar 31, 2024 | 109 | 7 | 6.86% |
| Dec 31, 2023 | 111 | 17 | 18.09% |
| Sep 30, 2023 | 108 | 15 | 16.13% |
| Jun 30, 2023 | 103 | 14 | 15.73% |
| Mar 31, 2023 | 102 | 16 | 18.60% |
| Dec 31, 2022 | 94 | 10 | 11.90% |
| Sep 30, 2022 | 93 | 8 | 9.41% |
| Jun 30, 2022 | 89 | 11 | 14.10% |
| Mar 31, 2022 | 86 | 12 | 16.22% |
| Dec 31, 2021 | 84 | 12 | 16.67% |
| Sep 30, 2021 | 85 | 12 | 16.44% |
| Jun 30, 2021 | 78 | 6 | 8.33% |
| Mar 31, 2021 | 74 | 5 | 7.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hansa Biopharma AB | 122 |
| Egetis Therapeutics AB | 42 |
| Genovis AB (publ.) | 36 |
| Vicore Pharma Holding AB | 36 |
| Saniona AB | 34 |
| Xspray Pharma AB | 26 |
| Cantargia AB | 22 |
| Medivir AB | 10 |
BioInvent International AB News
- 5 days ago - Resolutions at BioInvent's Annual General Meeting 2026 - Accesswire
- 5 days ago - BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio - Accesswire
- 5 days ago - BioInvent International AB: Interim Report January - March 2026 - Accesswire
- 13 days ago - BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting - Accesswire
- 4 weeks ago - BioInvent International AB Publishes Annual Report 2025 - Accesswire
- 5 weeks ago - BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis - Accesswire
- 5 weeks ago - Notice to Annual General Meeting in BioInvent International AB - Accesswire
- 2 months ago - BioInvent International AB (FRA:BIX0) Q4 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus